Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides
Tài liệu tham khảo
Mmbaga, 2011, Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania, East Afr. J. Public Health, 8, 28
Venkatesh, 2011, The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the Methods for Improving Reproductive Health in Africa study, Int. J. STD AIDS, 22, 218, 10.1258/ijsa.2010.010385
Wald, 2002, Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis, J. Infect. Dis., 185, 45, 10.1086/338231
Horbul, 2011, Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture, PLoS ONE, 6, e22638, 10.1371/journal.pone.0022638
Zhu, 2009, Persistence of HIV receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV acquisition, Nat. Med., 15, 886, 10.1038/nm.2006
Drannik, 2013, Antiviral activity of trappin-2 and elafin in vitroin vivo against genital herpes, J. Virol., 87, 7526, 10.1128/JVI.02243-12
Fakioglu, 2008, Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion, J. Virol., 82, 9337, 10.1128/JVI.00603-08
Sheth, 2008, Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation, J. Infect. Dis., 197, 1394, 10.1086/587697
Li, 2009, HSV-2 induces TLRs and NF-kappaB-dependent cytokines in cervical epithelial cells, Biochem. Biophys. Res. Commun., 379, 686, 10.1016/j.bbrc.2008.12.150
Goodkin, 2003, NF-kappa B is required for apoptosis prevention during herpes simplex virus type 1 infection, J. Virol., 77, 7261, 10.1128/JVI.77.13.7261-7280.2003
Asin, 2009, HIV type 1 infection in women: increased transcription of HIV type 1 in ectocervical tissue explants, J. Infect. Dis., 200, 965, 10.1086/605412
Rollenhagen, 2010, IL-8 decreases HIV-1 transmission in peripheral blood lymphocytes and ectocervical tissue explants, J. Acquir. Immune Defic. Syndr., 54, 463, 10.1097/QAI.0b013e3181e5e12c
Rollenhagen, 2011, Enhanced HIV-1 replication in ex vivo ectocervical tissues from post-menopausal women correlates with increased inflammatory responses, Mucosal Immunol., 4, 671, 10.1038/mi.2011.34
Krzyzowska, 2013, HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway, PLoS One, 8, e70308, 10.1371/journal.pone.0070308
Iijima, 2011, Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue, Proc. Natl. Acad. Sci. USA, 108, 284, 10.1073/pnas.1005201108
Nakanishi, 2009, CD8 (+) T lymphocyte mobilization to virus-infected tissue requires CD4 (+) T-cell help, Nature, 462, 510, 10.1038/nature08511
Lund, 2006, Cutting edge: plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ, J. Immunol., 177, 7510, 10.4049/jimmunol.177.11.7510
Koelle, 2000, Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection, J. Infect. Dis., 182, 662, 10.1086/315749
Biancotto, 2008, HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo, Blood, 111, 699, 10.1182/blood-2007-05-088435
McKinnon, 2012, Quality and quantity: mucosal CD4+ T cells and HIV susceptibility, Curr. Opin. HIV AIDS, 7, 195, 10.1097/COH.0b013e3283504941
Jaspan, 2011, Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding, J. Infect. Dis., 204, 1550, 10.1093/infdis/jir591
Shao, 2010, Keratinocytes play a role in the immunity to Herpes simplex virus type 2 infection, Acta Virol., 54, 261, 10.4149/av_2010_04_261
Thurman, 2012, Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention, Int. J. STD AIDS, 23, 613, 10.1258/ijsa.2012.011356
Abdool Karim, 2010, Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women, Science, 333, 1168, 10.1126/science.1193748
Josefsson, 2013, Single cell analysis of lymph node tissues from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule, PLoS Pathog., 9, e1003432, 10.1371/journal.ppat.1003432
Saba, 2010, HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model, Mucosal Immunol., 3, 280, 10.1038/mi.2010.2
Gorry, 2011, Coreceptors and HIV pathogenesis, Curr. HIV/AIDS Rep., 8, 45, 10.1007/s11904-010-0069-x
Grivel, 2007, HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1, AIDS, 21, 1263, 10.1097/QAD.0b013e3281864667
Margolis, 2006, Selective transmission of CCR5-utilizing HIV-1: the “gatekeeper” problem resolved?, Nat. Rev. Microbiol., 4, 312, 10.1038/nrmicro1387
Andrei, 2011, Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication, Cell Host Microbe, 10, 379, 10.1016/j.chom.2011.08.015
Grivel, 2009, Use of human tissue explants to study human infectious agents, Nat. Protoc., 4, 256, 10.1038/nprot.2008.245
Barnabas, 2012, Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions, Curr. HIV Res., 10, 228, 10.2174/157016212800618156
Cunningham, 2006, The cycle of human herpes simplex virus infection: virus transport and immune control, J. Infect. Dis., 194, S11, 10.1086/505359
Huang, 2012, Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4+ T cell migration via activation of p38-CCAAT/enhancer-binding protein-β pathway, J. Immunol., 188, 6247, 10.4049/jimmunol.1103706
Pham, 2006, Tenofovir disoproxil fumarate for the treatment of HIV infection, Expert Opin. Drug Metab. Toxicol., 2, 459, 10.1517/17425255.2.3.459
Dobard, 2012, Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue, J. Virol., 86, 718, 10.1128/JVI.05842-11
Grobler, 2012, Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial, AIDS, 26, 2261, 10.1097/QAD.0b013e328355ce08
Naranbhai, 2012, Innate immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel, J. Infect. Dis., 206, 993, 10.1093/infdis/jis465
Robbins, 2003, Metabolism of tenofovir and didanosine in quiescent or stimulated human peripheral blood mononuclear cells, Pharmacotherapy, 23, 695, 10.1592/phco.23.6.695.32189
Balzarini, 2002, Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells, AIDS, 16, 2159, 10.1097/00002030-200211080-00008
Goicoechea, 2010, Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients, AIDS, 24, 707, 10.1097/QAD.0b013e32833676eb
Ballzarini, 2013, A Multi-targeted drug candidate with dual anti-HIV and anti-HSV activity, PloS Pathog., 9, e1003456, 10.1371/journal.ppat.1003456
Johnson, 2012, A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis, Antimicrob. Agents Chemother., 56, 6272, 10.1128/AAC.01431-12
Smith, 2013, Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges, Proc. Natl. Acad. Sci. USA, 110, 16145, 10.1073/pnas.1311355110